Health ❯ Healthcare ❯ Clinical Trials

Treatment Efficacy

Combination Therapy Comparative Effectiveness Niktimvo Ruxolitinib for Vitiligo Neurological Impact Zycubo Injection Comparative Effectiveness Research Guselkumab vs Other Treatments Yeztugo Asthma Treatments Myeloma Treatments Intravenous Administration of Leqembi Sickle Cell Disease E1912 Trial Inlexzo Survival Rates

NICE Recommends First Vitiligo Repigmentation Cream for NHS Use in England

NHS England plans to offer ruxolitinib to nearly 100,000 eligible people within about three months after striking a deal with Incyte.

FDA Approves Zycubo, First U.S. Treatment for Menkes Disease

Shorter, Chemo-Free Strategies Match or Beat Standard Care in Adult Leukemias at ASH